INS and type 1 diabetes mellitus: The preclinical phase of T1D can be divided into two stages, with an initial stage of immune recognition and antibody production, beta cell and pancreatic destruction, followed by an exacerbation of islet destruction that leads to insulin production impairment and dysglycaemia (15).